Latest News

Top 10 pharma layoffs of 2011

The general upheaval in the pharma business kept employees on edge and HR departments busy drafting layoff notices last year. Drugmakers slashed thousands of jobs in 2011 to withstand the monumental challenges and dangers they face, and our annual layoff report provides key figures, dates and themes related to the industry's top 10 layoffs.

Launch the report =>

10 unusual biotech and pharma logos

Welcome to our second annual look at the most unusual logos in pharma and biotech. This year we found logos featuring lions, bears, smiling beakers, stick figures and a host of other puzzling images. These off-beat logos offer quite an alternative to the slick, polished images sported by most biopharma companies. Click here to start the slideshow

Biotech's Biggest Spenders 2011

If you add up the R&D budgets for the top 15 public biotechs in the world, you'll find a tab that runs right about $10 billion. That's not small change, by any means, but to put it in some perspective, it is interesting to note that Roche, which has the largest research budget for any biopharma on the planet, spent a bit more than that last year advancing new drugs and technology. Having noted that, we believe that a combination of the peak projected sales for all the experimental drugs you'll find in the biotech pipeline below would rival all that Roche is working on. This year, we've decided to sharpen the focus for our report on the biggest biotech R&D spenders. We've excluded some of the tool and tech companies that were on last year's Top 15 report so we can devote our attention to drug discovery and development. Report